M Mat Baki1, R Yu2, J S Rubin3, E Chevretton4, G Sandhu5, M A Birchall1. 1. Ear Institute,University College London,UK. 2. Joint Research Office,University College London,UK. 3. Royal National Throat,Nose and Ear Hospital,University College London Hospital NHS Trust,UK. 4. Guy's and St Thomas' NHS Trust,London,UK. 5. Charing Cross Hospital,Imperial College Healthcare NHS Trust,London,UK.
Abstract
OBJECTIVES: To explore unilateral vocal fold paralysis patients' perception of a proposed randomised, controlled trial of laryngeal reinnervation versus thyroplasty, and to identify patients' concerns regarding their voice. METHODS: Seventeen patients from five voice clinics in London were identified as being eligible for the randomised, controlled trial. Eleven of these patients (9 females and 2 males; age range, 18-65 years) were interviewed using a semi-structured topic guide (they were given a minimum of 2 weeks to read through the study information sheet). The interviews were recorded, transcribed and analysed using thematic analysis. RESULTS: The patients were satisfied with the clarity of the information sheet. Most of them perceived that reinnervation was a more 'attractive' option than thyroplasty. This may have been the result of certain phraseology used in the information sheet and by recruiters. Patients' main concern was reduced voice strength and the effects of this on work and social life. CONCLUSION: Phraseology that needed changing was identified; these changes may optimise the recruitment process for a trial. We propose using the voice handicap index 10 as the primary measure of outcome in the proposed randomised, controlled trial.
OBJECTIVES: To explore unilateral vocal fold paralysis patients' perception of a proposed randomised, controlled trial of laryngeal reinnervation versus thyroplasty, and to identify patients' concerns regarding their voice. METHODS: Seventeen patients from five voice clinics in London were identified as being eligible for the randomised, controlled trial. Eleven of these patients (9 females and 2 males; age range, 18-65 years) were interviewed using a semi-structured topic guide (they were given a minimum of 2 weeks to read through the study information sheet). The interviews were recorded, transcribed and analysed using thematic analysis. RESULTS: The patients were satisfied with the clarity of the information sheet. Most of them perceived that reinnervation was a more 'attractive' option than thyroplasty. This may have been the result of certain phraseology used in the information sheet and by recruiters. Patients' main concern was reduced voice strength and the effects of this on work and social life. CONCLUSION: Phraseology that needed changing was identified; these changes may optimise the recruitment process for a trial. We propose using the voice handicap index 10 as the primary measure of outcome in the proposed randomised, controlled trial.
Authors: Helen Blackshaw; Paul Carding; Marcus Jepson; Marina Mat Baki; Gareth Ambler; Anne Schilder; Stephen Morris; Aneeka Degun; Rosamund Yu; Samantha Husbands; Helen Knowles; Chloe Walton; Yakubu Karagama; Kate Heathcote; Martin Birchall Journal: BMJ Open Date: 2017-09-29 Impact factor: 2.692